NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update

Date: July 15, 2014
Pages: 22
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: N9F1E6878F5EN
Leaflet:

Download PDF Leaflet

NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update
Summary

NAL Pharmaceuticals Ltd. (NAL Pharma) is a pharmaceutical company. The company develops specialty drug products. It applies its drug delivery system technologies to develop novel dosage forms and delivery systems. NAL Pharma's technologies include Bio-D3 Extended-Release Transdermal Patch DDS, Bio-CR Extended-Release Nano-Particle DDS, Bio-FX Fast-Onset Oral-Cavity ODF, and Bio-MM Extended-Release Macromolecular DDS. The company's products serve therapeutic areas, such as central nervous system, oncology, arthritic and acute pain, smoking cessation, cardiovascular and allergy, and respiratory. It has presence in Japan, China, Hong Kong, Taiwan, and the US. NAL Pharma is headquartered in Causeway Bay, Hong Kong.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company NAL Pharmaceuticals Ltd.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
NAL Pharmaceuticals Ltd. Company Snapshot
NAL Pharmaceuticals Ltd. Company Overview
Key Information
NAL Pharmaceuticals Ltd. Pipeline Products and Clinical Trials Overview
NAL Pharmaceuticals Ltd. – Pipeline Analysis Overview
Key Facts
NAL Pharmaceuticals Ltd. - Major Products and Services
NAL Pharmaceuticals Ltd. Pipeline Products by Development Stage
NAL Pharmaceuticals Ltd. Pipeline Products Overview
Diclofenac Sodium 1-Day Patch
Diclofenac Sodium 1-Day Patch Product Overview
Donepezil 7-Day Patch
Donepezil 7-Day Patch Product Overview
Fentanyl 3-Day Patch
Fentanyl 3-Day Patch Product Overview
Galantamine 3-Day Patch
Galantamine 3-Day Patch Product Overview
Granisetron 7-Day Patch
Granisetron 7-Day Patch Product Overview
Lidocaine 5% Hydrogel Patch
Lidocaine 5% Hydrogel Patch Product Overview
Nicotine 1-Day Patch
Nicotine 1-Day Patch Product Overview
Rivastigmine 1-Day Patch
Rivastigmine 1-Day Patch Product Overview
Tulobuterol 1-Day Patch
Tulobuterol 1-Day Patch Product Overview
NAL Pharmaceuticals Ltd. - Key Competitors
NAL Pharmaceuticals Ltd. - Locations And Subsidiaries
Head Office
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

NAL Pharmaceuticals Ltd., Key Facts
NAL Pharmaceuticals Ltd. Pipeline Products and Clinical Trials Overview
NAL Pharmaceuticals Ltd. Pipeline Products by Equipment Type
NAL Pharmaceuticals Ltd. Pipeline Products by Indication
NAL Pharmaceuticals Ltd., Key Facts
NAL Pharmaceuticals Ltd., Major Products and Services
NAL Pharmaceuticals Ltd. Number of Pipeline Products by Development Stage
NAL Pharmaceuticals Ltd. Pipeline Products Summary by Development Stage
Diclofenac Sodium 1-Day Patch - Product Status
Diclofenac Sodium 1-Day Patch - Product Description
Donepezil 7-Day Patch - Product Status
Donepezil 7-Day Patch - Product Description
Fentanyl 3-Day Patch - Product Status
Fentanyl 3-Day Patch - Product Description
Galantamine 3-Day Patch - Product Status
Galantamine 3-Day Patch - Product Description
Granisetron 7-Day Patch - Product Status
Granisetron 7-Day Patch - Product Description
Lidocaine 5% Hydrogel Patch - Product Status
Lidocaine 5% Hydrogel Patch - Product Description
Nicotine 1-Day Patch - Product Status
Nicotine 1-Day Patch - Product Description
Rivastigmine 1-Day Patch - Product Status
Rivastigmine 1-Day Patch - Product Description
Tulobuterol 1-Day Patch - Product Status
Tulobuterol 1-Day Patch - Product Description

LIST OF FIGURES

NAL Pharmaceuticals Ltd. Pipeline Products by Equipment Type
NAL Pharmaceuticals Ltd. Pipeline Products by Development Stage
Skip to top


Ask Your Question

NAL Pharmaceuticals Ltd. - Product Pipeline Analysis, 2014 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: